EMBL-EBI is hosting the July Cambridge New Therapeutics Forum (CamNTF) event.

The meeting is open to all scientists researching new therapeutics in Cambridge and the local area. The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development.

Meeting attendance is free, but all attendees must register in advance.
Registration closes on 12 July.

Programme:

17:30-18:00 Welcome, refreshments and networking

18:00 Dr Matt Hall, Senior Scientific Officer, Industry Partnerships, EMBL-EBI.
Welcome and introduction to CamNTF

18:05 Dr Maria Falaguera, Postdoctoral Fellow (Leach Group), EMBL-EBI
Advancing early identification of novel drug targets

18:25 Dr Gabriele Picco, Senior Staff Scientist, Translational Cancer Genomics team, Wellcome Sanger Institute
Functional genomics of microsatellite unstable tumors and therapeutic target discovery

18:45 Professor Julio Saez-Rodriguez, Head of Research, EMBL-EBI
Knowledge-based machine learning to extract disease mechanisms from multi-omics data

19:05 Buffet and networking

20:00 Meeting Close